0 NASDAQ Companies - April 14, 2025Cue Biopharma Announces Pricing of Approximately $20 Million Public OfferingBOSTON, April 14, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class […]Read More
0 TSX News - April 14, 2025PrairieSky Announces Results of the Annual Meeting of ShareholdersCALGARY, Alberta, April 14, 2025 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky” or the “Company“) (TSX: PSK) is pleased to […]Read More
0 NASDAQ Companies - April 14, 2025HAOXIN HOLDINGS LIMITED Announces Pricing of Initial Public OfferingNingbo, China, April 14, 2025 (GLOBE NEWSWIRE) — Haoxin Holdings Limited (“Haoxin” or the “Company”) (NasdaqCM: HXHX), a provider of […]Read More
0 NASDAQ Companies - April 14, 2025MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]Read More
0 NASDAQ Companies - April 14, 2025Preferred Bank Announces 2025 First Quarter Earnings Release and Conference CallLOS ANGELES, April 14, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in […]Read More
0 NYSE Companies - April 14, 2025Vornado’s Retail JV Completes $450 Million Financing of 1535 BroadwayNEW YORK, April 14, 2025 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE:VNO) announced today that its 52% owned street retail […]Read More
0 NYSE Companies - April 14, 2025FEMSA Anuncia Conferencia Telefónica para Comentar sus Resultados del Primer TrimestrMONTERREY, México, April 14, 2025 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” o la “Compañía”) (NYSE: FMX; […]Read More
0 NASDAQ Companies - April 14, 2025AMD Achieves First TSMC N2 Product Silicon Milestone— Next-generation AMD EPYC CPU, codenamed “Venice,” is the first HPC product to be brought up on TSMC’s next-generation N2 […]Read More
0 NASDAQ Companies - April 14, 2025Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results– Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot […]Read More
0 TSX News - April 14, 2025Mullen Group Ltd. To Acquire Leading Customs Brokerage CompanyOKOTOKS, Alberta, April 14, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group“, “We“, “Our” and/or the “Corporation“) […]Read More